Financial News
Latest News about Sunshine Biopharma
Recent news which mentions Sunshine Biopharma
Insider Buying: Sunshine Biopharma Inc. (NASDAQ: SBFM) Chief Financial Officer Purchases Shares
December 12, 2022
Tickers
SBFM
From Benzinga
Chinese Lockdown Effects Ripple Marketwide; A Solution Urgently Needed
December 08, 2022
From Benzinga
What Does Sunshine Biopharma's Acquisition Of Nora Pharma Mean For The Generic Prescription Drugs Market?
November 07, 2022
From Benzinga
Sunshine Biopharma's Essential 9 Supplement Marks The Pharma Company's Entry Into $152 Billion Dietary Supplement Market
August 30, 2022
From Benzinga
From Benzinga
Sunshine Biopharma Q2 Report Reveals Approximately 1,940% Increase In Cash & Cash Equivalents And 80% Decrease In Net Loss Within 6 Months
August 08, 2022
From Benzinga
SUNSHINE BIOPHARMA INCREASES SUPPORT FOR ANTI-CORONAVIRUS COLLABORATIVE RESEARCH WITH THE UNIVERSITY OF ARIZONA
July 28, 2022
From Benzinga
Sunshine Biopharma States It Is Developing COVID Antiviral That Could Play Important Role In Treating Endemic COVID
June 08, 2022
From Benzinga
Sunshine Biopharma Prepares For IND Study Of Novel Cancer Drug That It Expects Could Beat Multidrug-Resistant Cancer
May 26, 2022
From Benzinga
Sunshine Biopharma Boasts Of Management Team With Wealth Of Medical And Scientific Knowledge
May 03, 2022
Tickers
SBFM
From Benzinga
Sunshine Biopharma Reveals Potential Intellectual Property Position In Connection With Ongoing mRNA-As-Therapeutics-Agents Research
April 26, 2022
From Benzinga
From Benzinga
From Benzinga
Sunshine Biopharma's $8 Million Private Placement Injects New Funding For Drug Development
March 24, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
